Anemia Drugs Market Research Report Information, by Anemia Type (Iron Deficiency Anemia, Sickle Cell Anemia, Aplastic Anemia, Hemolytic Anemia, Pernicious Anemia and others), by Route of Administration (Oral and Injectable), by Product Type (Biologics and Non-Biologics), End User (Hospitals and Self-Administered) - Forecast to 2032

Table of Contents

1 Introduction

1.1 Definition

1.2 Scope of Study

1.3 Research Objective

1.4 Assumptions & Limitations

1.5 Market Structure

2 Research Methodology

2.1 Research Process

2.2 Primary Research

2.3 Secondary Research

3 Market Dynamics

3.1 Drivers

3.2 Restraints

3.3 Opportunities

3.4 Challenges

3.5 Macroeconomic Indicators

4 Market Factor Analysis

4.1 Porter’s five forces model

4.1.1 Bargaining Power of suppliers

4.1.2 Bargaining Power of Customer

4.1.3 Intensity of Competitor’s

4.1.4 Threat of New Entrants

5 Global Anemia Drugs Market, by Anemia Type

5.1 Introduction

5.2 Iron deficiency anemia

5.3 Sickle Cell Anemia

5.4 Aplastic Anemia

5.5 Hemolytic anemia

5.6 Pernicious Anemia

5.7 Others

6 Global Anemia Drugs Market, By Route of Administration

6.1 Introduction

6.2 Oral

6.3 Injectable

7 Global Anemia Drugs Market, By Product Type

7.1 Introduction

7.2 Biologics

7.3 Non-biologics

8 Global Anemia Drugs Market, By End User

8.1 Introduction

8.2 Hospital

8.3 Self-administered

8.4 Others

9 Global Anemia Drugs market, by Regions

9.1 Introduction

9.1.1 Americas

9.1.1.1 North America

9.1.1.2 South America

9.1.2 Europe

9.1.2.1 Germany

9.1.2.2 France

9.1.2.3 UK

9.1.2.4 Italy

9.1.2.5 Spain

9.1.2.6 Rest of Europe

9.1.3 Asia Pacific

9.1.3.1 Japan

9.1.3.2 China

9.1.3.3 India

9.1.3.4 Republic of Korea

9.1.3.5 Rest of Asia Pacific

9.1.4 Middle East & Africa

10 Company Landscape

10.1 Introduction

10.1.1 Mergers Acquisitions

10.1.2 Collaborations

10.1.3 Release/New Product Launches

10.1.4 Other (Expansion, Updates, Partnership)

11 Company Profile

11.1 Amgen Inc.

11.1.1 Company Overview

11.1.2 Product/Business Segment Overview

11.1.3 Financials

11.1.4 Key Developments

11.1.5 SWOT Analysis

11.2 GlaxoSmithKline plc

11.2.1 Overview

11.2.2 Product/Business Segment Overview

11.2.3 Financials

11.2.4 Key Developments

11.2.5 SWOT Analysis

11.3 Bluebird bio

11.3.1 Overview

11.3.2 Product/Business Segment Overview

11.3.3 Financials

11.3.4 Key Developments

11.3.5 SWOT Analysis

11.4 Biocon

11.4.1 Overview

11.4.2 Product/Business Segment Overview

11.4.3 Financials

11.4.4 Key Developments

11.4.5 SWOT Analysis

11.5 GlycoMimetics Inc.

11.5.1 Overview

11.5.2 Product/Business Segment Overview

11.5.3 Financials

11.5.4 Key Developments

11.5.5 SWOT Analysis

11.6 Regen biopharma Inc.

11.6.1 Overview

11.6.2 Product/Business Segment Overview

11.6.3 Financials

11.6.4 Key Developments

11.6.5 SWOT Analysis

11.7 Bayer AG

11.7.1 Overview

11.7.2 Product/Business Segment Overview

11.7.3 Financials

11.7.4 Key Developments

11.7.5 SWOT Analysis

11.7 Acceleron Pharma

11.7.1 Overview

11.7.2 Product/Business Segment Overview

11.7.3 Financials

11.7.4 Key Developments

11.7.5 SWOT Analysis

11.8 Eli Lilly and company

11.8.1 Overview

11.8.2 Product/Business Segment Overview

11.8.3 Financials

11.8.4 Key Developments

11.8.5 SWOT Analysis

11.9 Others

11.9.1 Overview

11.9.2 Product/Business Segment Overview

11.9.3 Financials

11.9.4 Key Developments

11.9.5 SWOT Analysis

12 Others

13 Appendix

List of Tables

TABLE 1 GLOBAL ANEMIA DRUGS MARKET, 2020-2027 (USD MILLION)

TABLE 2 GLOBAL ANEMIA DRUGS MARKET, BY ANEMIA TYPE, 2020-2027 (USD MILLION)

TABLE 3 GLOBAL ANEMIA DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION)

TABLE 4 GLOBAL ANEMIA DRUGS MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION)

TABLE 5 GLOBAL ANEMIA DRUGS MARKET, BY END USER, 2020-2027 (USD MILLION)

TABLE 6 GLOBAL ANEMIA DRUGS MARKET, BY REGION, 2020-2027 (USD MILLION)

List of Figures

FIGURE 1 RESEARCH PROCESS

FIGURE 2 PORTERS FIVE FORCES MODEL

FIGURE 3 GLOBAL ANEMIA DRUGS MARKET, BY ANEMIA TYPE

FIGURE 4 GLOBAL ANEMIA DRUGS MARKET, BY ROUTE OF ADMINISTRATION

FIGURE 5 GLOBAL ANEMIA DRUGS MARKET, BY PRODUCT TYPE

FIGURE 6 GLOBAL ANEMIA DRUGS MARKET, BY END USER

FIGURE 7 GLOBAL ANEMIA DRUGS MARKET, BY REGION

FIGURE 8 GLOBAL ANEMIA DRUGS MARKET: COMPANY SHARE ANALYSIS, 2020 (%)